QQQ   430.57 (-0.11%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.82 (-1.80%)
BABA   69.92 (-0.99%)
T   16.00 (-1.48%)
F   12.14 (-0.74%)
MU   121.04 (-0.27%)
GE   155.38 (+1.09%)
CGC   6.84 (-2.01%)
DIS   113.72 (+0.68%)
AMC   2.88 (+16.60%)
PFE   25.76 (-0.58%)
PYPL   63.66 (+0.24%)
XOM   118.19 (-1.24%)
QQQ   430.57 (-0.11%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.82 (-1.80%)
BABA   69.92 (-0.99%)
T   16.00 (-1.48%)
F   12.14 (-0.74%)
MU   121.04 (-0.27%)
GE   155.38 (+1.09%)
CGC   6.84 (-2.01%)
DIS   113.72 (+0.68%)
AMC   2.88 (+16.60%)
PFE   25.76 (-0.58%)
PYPL   63.66 (+0.24%)
XOM   118.19 (-1.24%)
QQQ   430.57 (-0.11%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.82 (-1.80%)
BABA   69.92 (-0.99%)
T   16.00 (-1.48%)
F   12.14 (-0.74%)
MU   121.04 (-0.27%)
GE   155.38 (+1.09%)
CGC   6.84 (-2.01%)
DIS   113.72 (+0.68%)
AMC   2.88 (+16.60%)
PFE   25.76 (-0.58%)
PYPL   63.66 (+0.24%)
XOM   118.19 (-1.24%)
QQQ   430.57 (-0.11%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.82 (-1.80%)
BABA   69.92 (-0.99%)
T   16.00 (-1.48%)
F   12.14 (-0.74%)
MU   121.04 (-0.27%)
GE   155.38 (+1.09%)
CGC   6.84 (-2.01%)
DIS   113.72 (+0.68%)
AMC   2.88 (+16.60%)
PFE   25.76 (-0.58%)
PYPL   63.66 (+0.24%)
XOM   118.19 (-1.24%)
NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

$9.87
+0.26 (+2.71%)
(As of 01:51 PM ET)
Today's Range
$9.45
$9.90
50-Day Range
$5.71
$11.53
52-Week Range
$1.40
$12.01
Volume
219,018 shs
Average Volume
829,810 shs
Market Capitalization
$398.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.20

LifeMD MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
7.1% Upside
$10.20 Price Target
Short Interest
Bearish
8.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.92mentions of LifeMD in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.14) to ($0.31) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.25 out of 5 stars

Medical Sector

896th out of 928 stocks

Offices & Clinics Of Medical Doctors Industry

7th out of 7 stocks

LFMD stock logo

About LifeMD Stock (NASDAQ:LFMD)

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LFMD Stock Price History

LFMD Stock News Headlines

LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD Inc. NASDAQ: LFMD provides telehealth services to consumers in the United States. The medical sector company operates many telehealth brands, including men's telehealth brands RexMD and ShapiroMD, NavaMD female dermatology telehealth, Cleared Allergy Clinic, and LifeMD Primary Care.
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
LifeMD Full Year 2023 Earnings: Beats Expectations
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
LifeMD Shares Jump on Strong 4Q
LifeMD Reports Fourth Quarter 2023 Results
Here's what to expect from LifeMD's earnings
Get Your Shopping List Ready: Here's How to Buy Pullbacks
LifeMD Insiders Placed Bullish Bets Worth US$1.24m
Best Iodine Supplements Of 2024
LifeMD Provides 2024 Financial Guidance
See More Headlines
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/11/2024
Today
4/16/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
207
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.20
High Stock Price Target
$13.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+7.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-20,600,000.00
Pretax Margin
-11.41%

Debt

Sales & Book Value

Annual Sales
$152.55 million
Book Value
$0.15 per share

Miscellaneous

Free Float
32,741,000
Market Cap
$384.32 million
Optionable
Optionable
Beta
1.43
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Justin SchreiberMr. Justin Schreiber (Age 41)
    Chairman & CEO
    Comp: $255k
  • Mr. Marc Benathen (Age 43)
    Chief Financial Officer
    Comp: $378.75k
  • Mr. Eric H. Yecies (Age 46)
    Chief Legal Officer, General Counsel & Secretary
    Comp: $332k
  • Ms. Maria E. Stan CPA (Age 49)
    Controller & Principal Accounting Officer
  • Mr. Dennis Wijnker (Age 48)
    Chief Technology Officer
  • Mr. Shane Biffar
    Chief Compliance Officer & Deputy General Counsel
  • Ms. Jessica Friedeman (Age 40)
    Chief Marketing Officer
  • Mr. Stefan GalluppiMr. Stefan Galluppi (Age 37)
    Chief Innovation Officer
    Comp: $165k
  • Mr. Nicholas P. Alvarez (Age 42)
    Chief Acquisition Officer & Head of Customer Acquisition
    Comp: $141.11k
  • Mr. Varun Pathak
    Chief Software Engineer & Co-Founder of PDF Simpli

LFMD Stock Analysis - Frequently Asked Questions

Should I buy or sell LifeMD stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LFMD shares.
View LFMD analyst ratings
or view top-rated stocks.

What is LifeMD's stock price target for 2024?

5 brokers have issued twelve-month price targets for LifeMD's shares. Their LFMD share price targets range from $7.00 to $13.00. On average, they anticipate the company's share price to reach $10.20 in the next year. This suggests a possible upside of 7.1% from the stock's current price.
View analysts price targets for LFMD
or view top-rated stocks among Wall Street analysts.

How have LFMD shares performed in 2024?

LifeMD's stock was trading at $8.29 at the beginning of 2024. Since then, LFMD stock has increased by 14.8% and is now trading at $9.52.
View the best growth stocks for 2024 here
.

Are investors shorting LifeMD?

LifeMD saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,650,000 shares, an increase of 37.3% from the March 15th total of 1,930,000 shares. Based on an average daily trading volume, of 762,800 shares, the short-interest ratio is presently 3.5 days. Approximately 8.6% of the company's shares are short sold.
View LifeMD's Short Interest
.

When is LifeMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our LFMD earnings forecast
.

How were LifeMD's earnings last quarter?

LifeMD, Inc. (NASDAQ:LFMD) issued its earnings results on Monday, March, 11th. The company reported ($0.12) EPS for the quarter, beating analysts' consensus estimates of ($0.14) by $0.02. The company earned $44.86 million during the quarter, compared to the consensus estimate of $40.65 million.

What ETF holds LifeMD's stock?

Invesco Dorsey Wright Healthcare Momentum ETF holds 140,399 shares of LFMD stock, representing 0.98% of its portfolio.

What guidance has LifeMD issued on next quarter's earnings?

LifeMD updated its first quarter 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $42.0 million-$43.0 million, compared to the consensus revenue estimate of $42.5 million.

How do I buy shares of LifeMD?

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LFMD) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners